6min chapter

The Top Line cover image

Fulfilling the promise of cell & gene therapies through manufacturing (Part I)

The Top Line

CHAPTER

Revamping Supply Chains and Accelerating Cell Therapy Reach

Exploring the speaker's journey in developing single-dose curative treatments, the chapter emphasizes the creation of an internal biotech group within MD Anderson Cancer Center to optimize processes and facilitate the translation of products from research to clinical phases. Through collaborations with companies like Obsidian Therapeutics and successful clinical outcomes, the importance of partnerships in expediting the availability of cell therapies to patients is underscored.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode